A new virtual injection service has emerged, targeting the popularity of the weight loss drug 'Mounjaro.' Named 'Maumjaro,' this service offers users an experience of receiving an injection by simply placing their smartphone on their abdomen, without administering any actual medication.
Doctor Now, a telemedicine platform, recently launched 'Maumjaro,' a virtual experience service parodying Mounjaro.
The Maumjaro page is designed to resemble an actual pharmaceutical purchase screen. The price is displayed with a strikethrough at 350,000 won, now marked as 0 won.
Users can select their desired dosage, ranging from 2.5 mg to 15 mg, and then place the on-screen syringe on their abdomen. The virtual medication in the syringe gradually decreases, simulating the injection process.
The service's name is derived from Mounjaro, a weight loss and diabetes treatment developed by the American pharmaceutical company Eli Lilly. Mounjaro is an injectable medication containing tirzepatide, which works on both GLP-1 and GIP receptors to help reduce appetite and food intake, aiding in weight loss.
Maumjaro's marketing strategy appears to target both the high recognition of Mounjaro and the cost concerns associated with it. By offering a free virtual experience, it aims to attract users who are interested in expensive weight loss treatments but hesitant to undergo actual injections.
Mounjaro is a prescription medication that requires a doctor's consultation and prescription. Doctor Now also clarifies that Maumjaro does not advertise any specific medications or provide actual weight loss effects. The decision to use a weight loss drug and its dosage should be made in consultation with healthcare professionals, considering individual health conditions and potential side effects.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.